Science Immunology

The PDF file includes:

  • Fig. S1. Gating strategy, MAIT cell abundance and alteration of soluble factors in COVID-19 patients.
  • Fig. S2. Phenotypic alterations of peripheral blood MAIT cells and other T cell subsets in COVID-19 patients.
  • Fig. S3. Transcriptional profiling of the MAIT cell compartment in the upper respiratory tract.
  • Fig. S4. Associations and correlations of MAIT cell count and phenotype with clinical parameters, cytokine and chemokine levels in serum.
  • Fig. S5. Phenotypic comparison of peripheral blood MAIT cells in acute and convalescent COVID-19 patients.
  • Table S1. Demographic and clinical characteristics of the acute COVID-19 Atlas cohort, healthy donors, and convalescent patients.
  • Table S2. Demographic and clinical characteristics of the COVID-19 Biobank cohort patients.
  • Table S3. Demographic and clinical data comparison between the acute COVID-19 Atlas cohort and the Biobank cohort.

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Table S4. Raw data file (Excel spreadsheet).